This topic contains a solution. Click here to go to the answer

Author Question: In the Microsoft SQL Server Management Studio, the amount to add to the surrogate key value when ... (Read 81 times)

tth

  • Hero Member
  • *****
  • Posts: 579
In the Microsoft SQL Server Management Studio, the amount to add to the surrogate key value when adding a new row is specified by the increment property.
 
  Indicate whether the statement is true or false

Question 2

The data model produced by reverse engineering may include some entities that should not appear in the data model.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Cnarkel

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

TRUE

Answer to Question 2

TRUE




tth

  • Member
  • Posts: 579
Reply 2 on: Jul 7, 2018
Thanks for the timely response, appreciate it


kilada

  • Member
  • Posts: 311
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library